gastroparesis
Information
- Disease name
- gastroparesis
- Disease ID
- DOID:11914
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04300127 | Active, not recruiting | Early Phase 1 | Pioglitazone for Idiopathic Gastroparesis | October 24, 2019 | October 29, 2025 |
| NCT03626350 | Active, not recruiting | Prospective Evaluation of the Efficacy and Safety of Submucosal Endoscopy | June 12, 2018 | June 12, 2025 | |
| NCT05004012 | Active, not recruiting | N/A | Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility | December 1, 2021 | August 2024 |
| NCT05718505 | Active, not recruiting | N/A | Comparison of the Atmo Motility Gas Capsule System to the Reference Standard | June 5, 2023 | April 2024 |
| NCT04282317 | Active, not recruiting | N/A | Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis | August 1, 2019 | December 31, 2026 |
| NCT02567175 | Available | Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders | |||
| NCT04996134 | Available | Domperidone Expanded Access Treatment Program | |||
| NCT04474990 | Available | Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis | |||
| NCT00501657 | Completed | Phase 1 | Effects of Sitagliptin on Gastric Emptying in Healthy Subjects | July 2007 | December 2011 |
| NCT00562848 | Completed | Phase 1 | A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 | September 10, 2007 | June 27, 2008 |
| NCT00612014 | Completed | Phase 2 | Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis | October 2007 | March 2009 |
| NCT00639808 | Completed | Phase 1 | Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis | August 2006 | March 2008 |
| NCT00682877 | Completed | A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old | July 2007 | November 2007 | |
| NCT00733551 | Completed | Phase 1 | Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. | September 23, 2008 | July 20, 2009 |
| NCT01394055 | Completed | Phase 1 | Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis | July 2011 | December 2012 |
| NCT00050882 | Completed | Phase 2 | Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis | ||
| NCT00128284 | Completed | A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time | February 2005 | October 2005 | |
| NCT00370084 | Completed | Phase 1/Phase 2 | Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia | March 2005 | July 2006 |
| NCT00372970 | Completed | N/A | Placebo Controlled Trial of Botulinum Toxin for Gastroparesis | July 2003 | December 2008 |
| NCT00398801 | Completed | Gastroparesis Registry | December 2006 | March 2011 | |
| NCT00432835 | Completed | Phase 3 | Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis | August 2005 | November 2007 |
| NCT00492622 | Completed | Phase 4 | Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis | June 2007 | December 2008 |
| NCT00845858 | Completed | Phase 2 | Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis | April 2009 | December 2011 |
| NCT00861809 | Completed | Phase 2 | The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis | June 2009 | November 2010 |
| NCT00889486 | Completed | Phase 2 | Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus | April 2009 | April 2010 |
| NCT00903799 | Completed | N/A | Medico-economic Evaluation of ENTERRA Therapy | June 2009 | November 2015 |
| NCT01039805 | Completed | Phase 2 | Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance | December 2009 | July 2011 |
| NCT01039974 | Completed | Phase 1 | GSK962040 Drug-drug Interaction Study With Ketoconazole | September 18, 2009 | November 30, 2009 |
| NCT01054794 | Completed | N/A | Temporary Gastric Electrical Stimulation for Gastroparesis | December 2009 | December 2011 |
| NCT01074710 | Completed | Phase 1 | Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers | February 2010 | May 2010 |
| NCT01135186 | Completed | N/A | Impact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis. | May 2010 | November 2012 |
| NCT01149369 | Completed | Phase 2 | Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial | April 2013 | September 2015 |
| NCT01206582 | Completed | Phase 2 | A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus) | May 2010 | December 2014 |
| NCT01262898 | Completed | Phase 2 | Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis | May 3, 2011 | February 26, 2013 |
| NCT01267071 | Completed | Phase 1 | A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers | June 14, 2010 | September 1, 2010 |
| NCT01294566 | Completed | Phase 1 | FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers | November 29, 2010 | March 23, 2011 |
| NCT01316484 | Completed | Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms | March 2011 | April 2011 | |
| NCT00050609 | Completed | Phase 2 | Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying | February 2003 | September 2003 |
| NCT01452815 | Completed | Phase 2 | Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis | September 2011 | November 2012 |
| NCT01519180 | Completed | Antro-pyloro-duodenal Motility in Idiopathic Gastroparesis | January 2012 | January 2014 | |
| NCT01571297 | Completed | Phase 2 | Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis | April 2012 | September 2013 |
| NCT01602549 | Completed | Phase 2 | A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying | July 2012 | May 2014 |
| NCT01643577 | Completed | Phase 1/Phase 2 | Acupuncture Treatment for Gastroparesis: a Pilot Study | November 2011 | November 2013 |
| NCT01650714 | Completed | N/A | Endoscopic Full Thickness Biopsy, Gastric Wall. | September 2012 | September 2014 |
| NCT01696747 | Completed | Gastroparesis Registry 2 | July 2012 | April 30, 2019 | |
| NCT01718938 | Completed | Phase 2 | Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis | December 2012 | February 2014 |
| NCT01989221 | Completed | Phase 3 | Sancuso® for Gastroparesis: An Open Label Study. | November 2012 | December 2018 |
| NCT02031081 | Completed | Phase 2/Phase 3 | Prucalopride Versus Placebo in Gastroparesis | March 2014 | June 2018 |
| NCT02187094 | Completed | Phase 1/Phase 2 | Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis | June 2014 | January 2015 |
| NCT02210000 | Completed | Phase 2 | A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis | August 27, 2014 | August 24, 2015 |
| NCT02232308 | Completed | Phase 1 | Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects | July 2014 | September 2014 |
| NCT02267525 | Completed | Phase 2 | The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study | December 2014 | June 2017 |
| NCT02324010 | Completed | Phase 2 | Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes | July 2015 | January 2017 |
| NCT02357420 | Completed | Phase 2 | Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis | January 29, 2015 | June 9, 2016 |
| NCT02524496 | Completed | Limited Access Protocol for the Use of Oral Cisapride | March 2001 | March 2011 | |
| NCT02736799 | Completed | N/A | Effect of Vibrant Capsule on Gastric Emptying and Antropyloroduodenal Motility in Healthy Volunteers | March 2016 | |
| NCT02753010 | Completed | Gastric Emptying in Elderly With Hip Fracture | March 2011 | March 2016 | |
| NCT02779920 | Completed | N/A | Feasibility of Endoscopic Pylorotomy in the Treatment of Refractory Gastroparesis, Pilot Study. | April 2016 | July 2017 |
| NCT02838797 | Completed | Phase 1 | RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease | June 2016 | August 20, 2019 |
| NCT03178370 | Completed | Autonomic and Enteric Profiling | March 6, 2014 | December 3, 2015 | |
| NCT03259841 | Completed | Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy | October 31, 2017 | February 8, 2019 | |
| NCT03294616 | Completed | N/A | Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma | February 6, 2017 | November 20, 2019 |
| NCT03356067 | Completed | N/A | Endoscopic Pyloromyotomy for Refractory Gastroparesis | December 1, 2017 | January 26, 2021 |
| NCT03441230 | Completed | N/A | Determination of the Characteristics of Isometric Gastric Motility Measurement in Healthy Volunteers | February 15, 2016 | January 20, 2017 |
| NCT03587142 | Completed | Phase 2 | Buspirone for Early Satiety and Symptoms of Gastroparesis | August 27, 2019 | April 30, 2022 |
| NCT03679104 | Completed | N/A | Endoscopic Clips Versus Overstich Suturing System Device for Closure of Mucosotomy After G-POEM | November 1, 2018 | January 26, 2021 |
| NCT03680859 | Completed | Gastroparesis Registry 3 | January 24, 2019 | May 13, 2024 | |
| NCT03712124 | Completed | Phase 2 | A Study of CNSA-001 in Women With Diabetic Gastroparesis | February 27, 2019 | October 8, 2019 |
| NCT03941288 | Completed | Phase 2 | Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia | September 4, 2019 | February 23, 2023 |
| NCT04024709 | Completed | Long-term Results of Per-oral Pyloromyotomy for Refractory Gastroparesis | January 1, 2017 | April 1, 2019 | |
| NCT04026997 | Completed | Phase 2 | A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis | September 11, 2019 | December 17, 2020 |
| NCT04607304 | Completed | N/A | ABCA2 GIRMS Analytical Validation Clinical Performance Study | October 8, 2020 | July 27, 2021 |
| NCT04684992 | Completed | N/A | GEBT Telehealth Administration Usability Study | December 11, 2020 | March 10, 2021 |
| NCT04752670 | Completed | ConMed Beamer Study | May 27, 2021 | May 1, 2022 | |
| NCT04772261 | Completed | N/A | GEBT Lot-to-Lot and Biological Variability | February 5, 2021 | January 10, 2022 |
| NCT04857281 | Completed | N/A | Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients With Gastroparesis and Related Disorders | April 19, 2021 | January 23, 2024 |
| NCT04977063 | Completed | N/A | Atmo SmartPill Comparison in Gastroparetic and Slow Transit Constipation Patients | August 15, 2021 | March 15, 2023 |
| NCT05270460 | Completed | Phase 2 | Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis | March 9, 2022 | October 6, 2022 |
| NCT06215547 | Enrolling by invitation | N/A | Medtronic Enterra II Neurostimulator | September 15, 2015 | September 14, 2025 |
| NCT02159586 | Enrolling by invitation | Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve | November 2012 | December 2027 | |
| NCT04207996 | Enrolling by invitation | Vagus Nerve Response in Gastroparesis Patients | September 1, 2019 | August 31, 2026 | |
| NCT05047289 | Enrolling by invitation | Indiana University Gastric Electrical Stimulation Registry | October 20, 2020 | October 20, 2030 | |
| NCT05041608 | Enrolling by invitation | Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study | February 17, 2021 | December 16, 2024 | |
| NCT05812339 | Enrolling by invitation | Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls | November 1, 2022 | December 31, 2024 | |
| NCT02757534 | No longer available | Domperidone for Chronic Nausea and Vomiting | |||
| NCT03128398 | No longer available | Use of Domperidone for Treatment of Upper Gastrointestinal Disorders | |||
| NCT06394154 | Not yet recruiting | Validation of a Mental Health Scale for Young People With Chronic Stomach Symptoms | May 2024 | September 2024 | |
| NCT05846802 | Not yet recruiting | Gastroparesis Registry 4 | June 30, 2024 | April 30, 2027 | |
| NCT04661215 | Not yet recruiting | Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms | July 30, 2024 | December 2026 | |
| NCT04349670 | Not yet recruiting | Safety and Efficacy of GPOEM in the Treatment of Gastroparesis | June 1, 2020 | April 1, 2025 | |
| NCT05647135 | Not yet recruiting | ImpACt of Very High Protein Content Enteral nUtrition Formulas on Critically Ill MUltipLe trAuma paTiEnts | December 1, 2022 | December 1, 2024 | |
| NCT05981300 | Not yet recruiting | GpCRC Pediatric Gastroparesis Registry 2 | June 30, 2024 | June 30, 2027 | |
| NCT06173336 | Not yet recruiting | N/A | Comparison of Outcomes for Single vs Double Pyloromyotomy for Gastroparesis Randomized Controlled Trial | June 2024 | June 2026 |
| NCT05405842 | Not yet recruiting | N/A | Transauricular Vagal Nerve Stimulation; Functional Dyspepsia and Gastroparesis | May 2023 | May 2025 |
| NCT05039424 | Recruiting | N/A | Endoscopic Myotomy of the Pylorus To Improve Emptying and Symptoms Trial | February 23, 2022 | July 2026 |
| NCT05731531 | Recruiting | N/A | EGG Test as a Predictor for an Individual Response to Treatment by Various Bariatric Procedures | November 1, 2022 | December 2024 |
| NCT05789511 | Recruiting | HR-EGG in Medically Refractory Gastroparesis | December 1, 2022 | June 2025 | |
| NCT03011151 | Recruiting | Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical Illness | August 1, 2017 | December 31, 2023 | |
| NCT03123809 | Recruiting | N/A | Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis | January 10, 2017 | September 15, 2024 |
| NCT05795309 | Recruiting | N/A | Automated Insulin Delivery in Type 1 Diabetes Complicated by Gastroparesis | August 16, 2023 | June 30, 2024 |
| NCT05880199 | Recruiting | BSGM to Evaluate Patients With GI Symptoms | October 1, 2021 | December 31, 2025 | |
| NCT05905016 | Recruiting | Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders | October 1, 2021 | April 2027 | |
| NCT03531450 | Recruiting | N/A | Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients | December 7, 2018 | February 25, 2027 |
| NCT05980455 | Recruiting | N/A | Study of Enterra Programming With Nocturnal Cycling in Gastroparetics | July 10, 2023 | December 2024 |
| NCT03603730 | Recruiting | Early Phase 1 | Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis | November 30, 2018 | March 30, 2025 |
| NCT03680820 | Recruiting | Pediatric Gastroparesis Registry | January 23, 2019 | June 30, 2024 | |
| NCT06004596 | Recruiting | N/A | Establishing a Pediatric Reference Range for the 13C-Spirulina Gastric Emptying Breath Test (GEBT) | March 17, 2023 | October 31, 2024 |
| NCT06038734 | Recruiting | Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists. | November 10, 2023 | October 2024 | |
| NCT03876288 | Recruiting | Gastroparesis Outcome Longitudinal Database Enrolled Numerically | January 1, 2013 | January 1, 2026 | |
| NCT03896126 | Recruiting | GI-Challenge Study for Gastroparesis Patients and Healthy Controls | January 1, 2019 | February 1, 2025 | |
| NCT06068114 | Recruiting | Gastric Pathophysiology in Diabetes | October 5, 2022 | June 30, 2027 | |
| NCT06068127 | Recruiting | G-POEM for Refractory Gastroparesis After Esophagectomy With Gastric Pull-through | October 12, 2023 | March 22, 2024 | |
| NCT04028492 | Recruiting | Phase 3 | Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis | August 20, 2019 | December 2024 |
| NCT04208828 | Recruiting | IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy | January 2, 2020 | January 2, 2026 | |
| NCT04287647 | Recruiting | N/A | Transpyloric Stenting as a Predictor for G-POEM for Refractory Gastroparesis | May 15, 2019 | June 6, 2024 |
| NCT04434781 | Recruiting | Gastric Per-Oral Endoscopic Myotomy (G-POEM) for the Treatment of Gastroparesis | August 7, 2018 | August 15, 2026 | |
| NCT04506593 | Recruiting | Indiana University Gastrointestinal Motility Diagnosis Registry | November 2014 | November 2024 | |
| NCT06292065 | Recruiting | N/A | Gastric Ultrasound To Assess Gastric Contents In Patients On Semaglutide Therapy | April 16, 2024 | December 31, 2024 |
| NCT04696159 | Recruiting | N/A | Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes | January 4, 2023 | May 2025 |
| NCT04699591 | Recruiting | N/A | Compassionate Use of Domperidone for Refractory Gastroparesis | April 2013 | December 2035 |
| NCT06372132 | Recruiting | N/A | G-POEM vs PEG-J in Gastroparesis Patients | March 14, 2024 | January 1, 2028 |
| NCT06381349 | Recruiting | Predicting Outcomes of GPOEM Using Gastric Electrical Mapping | May 30, 2024 | June 1, 2026 | |
| NCT04869670 | Recruiting | N/A | A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis | July 12, 2023 | July 2025 |
| NCT06401746 | Recruiting | Body Surface Gastric Mapping in Patients on Semaglutide | May 1, 2024 | March 1, 2025 | |
| NCT01696734 | Recruiting | Phase 3 | Domperidone in Treating Patients With Gastrointestinal Disorders | October 23, 2012 | October 31, 2025 |
| NCT02165059 | Recruiting | GI Neuromuscular Pathology Prospective Registry | December 2013 | December 2025 | |
| NCT05229432 | Recruiting | Study of Gastric Motility in Eosinophilic Gastritis | January 25, 2023 | June 1, 2025 | |
| NCT06411574 | Recruiting | N/A | Body Surface Gastric Mapping vs Gastric Emptying Scintigraphy on Clinical Management in Gastroparesis | May 3, 2024 | December 3, 2026 |
| NCT05602272 | Recruiting | Respiratory and Hemodynamic Implications of Endoscopic Myotomy of the Esophagus and Stomach | November 1, 2022 | November 1, 2025 | |
| NCT05621811 | Recruiting | Phase 2 | Different Doses of Naronapride vs. Placebo in Gastroparesis | January 3, 2023 | April 2025 |
| NCT05624034 | Recruiting | To Study the EGG Abnormalities in Healthy Subjects and in Patients With Idiopathic and Diabetic Gastroparesis. | November 1, 2022 | October 2023 | |
| NCT05079568 | Suspended | N/A | A Study to Evaluate the Safety and Tolerability of Virtual Reality to Treat Gastroparesis | October 1, 2021 | December 2024 |
| NCT03810287 | Temporarily not available | The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms | |||
| NCT02227927 | Temporarily not available | Treatment Use of Domperidone for Gastroparesis | |||
| NCT00761254 | Terminated | N/A | Domperidone for Relief of Gastrointestinal Disorders | August 2008 | September 2012 |
| NCT04349891 | Terminated | N/A | Transcutaneous Electroacupuncture for Gastrointestinal Motility Disorders | October 1, 2020 | July 29, 2022 |
| NCT03786380 | Terminated | Phase 3 | Diabetic Gastroparesis Study 05 | December 20, 2018 | October 5, 2020 |
| NCT01173484 | Terminated | Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification | June 2010 | August 2011 | |
| NCT03383146 | Terminated | Phase 3 | A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04 | February 1, 2018 | November 5, 2020 |
| NCT01934192 | Terminated | Phase 2 | Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study | April 4, 2014 | July 8, 2016 |
| NCT03987672 | Terminated | N/A | Study to Intervene With Nutrition for Gastroparesis | August 1, 2019 | August 18, 2022 |
| NCT02164591 | Terminated | Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis | February 2013 | January 2019 | |
| NCT01281540 | Terminated | Phase 4 | An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options | May 2003 | November 2003 |
| NCT01286090 | Terminated | Phase 4 | An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus | July 2003 | October 2003 |
| NCT04844190 | Terminated | N/A | Use of EndoFLIP and Manometry Prior to G-POEM | September 15, 2021 | March 1, 2024 |
| NCT00552422 | Terminated | N/A | Domperidone for Gastroparesis in Solid Organ Transplantation | March 2007 | September 2010 |
| NCT01323582 | Terminated | Phase 2 | Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis | February 2009 | December 2012 |
| NCT00556166 | Terminated | Phase 4 | Enterra Therapy Gastric Stimulation System | October 2004 | September 2008 |
| NCT01329211 | Terminated | Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers | January 2010 | February 2013 | |
| NCT02057549 | Terminated | Phase 4 | Haloperidol vs Conventional Therapy for Gastroparesis | November 2012 | November 2016 |
| NCT00157755 | Terminated | N/A | Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis) | June 2002 | March 2009 |
| NCT03420781 | Terminated | Phase 3 | A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 | January 24, 2018 | October 30, 2020 |
| NCT03285308 | Terminated | Phase 3 | A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01 | September 29, 2017 | July 8, 2020 |
| NCT02022826 | Terminated | N/A | Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis | January 2014 | March 2017 |
| NCT00390975 | Terminated | Phase 4 | Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis | January 2007 | March 2007 |
| NCT04635306 | Terminated | N/A | 13C-Spirulina Nitrogen Content GEBT Study | October 21, 2020 | June 25, 2021 |
| NCT00760461 | Terminated | Phase 2 | Domperidone in Refractory Gastroparesis | October 2008 | July 2011 |
| NCT03120325 | Terminated | N/A | Vagal Nerve Stimulation for Gastroparesis | March 1, 2017 | August 24, 2018 |
| NCT01117376 | Terminated | Phase 2 | Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients | May 2010 | August 2011 |
| NCT03426345 | Terminated | Phase 3 | Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02 | February 16, 2018 | July 16, 2020 |
| NCT02927886 | Unknown status | Phase 3 | Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective Evaluation of Efficacy | November 2016 | March 2020 |
| NCT04552184 | Unknown status | N/A | GPOEM Versus SHAM as a Treatement of Gastroparesis | October 10, 2017 | December 1, 2021 |
| NCT02446119 | Unknown status | Pyloric Sphincter Pressure and Geometry Assessment Using EndoFlip | May 2015 | June 2021 | |
| NCT03089632 | Unknown status | N/A | The Effect of Gluten-free Diet in Type 1 Diabetics With Dyspepsia Symptoms | December 15, 2017 | June 30, 2018 |
| NCT02308254 | Unknown status | Phase 1/Phase 2 | Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People | November 2013 | April 2016 |
| NCT00227383 | Unknown status | Phase 3 | Effect of Electroacupuncture in Diabetic Patients With Gastroparesis | ||
| NCT02594397 | Unknown status | N/A | Acupuncture for Diabetic Gastroparalysis: a Randomized Controlled Trial | December 2015 | |
| NCT03438305 | Unknown status | Role of Gastric Ultrasound in Preoperative Assessment of Gastric Volume in Diabetic Patients. | March 1, 2018 | June 1, 2018 | |
| NCT02510976 | Unknown status | Phase 4 | Prucalopride Versus Placebo in Gastroparesis | November 2011 | |
| NCT02970968 | Unknown status | Phase 2 | Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis | November 2016 | December 2018 |
| NCT03802006 | Unknown status | Ultrasound Assessment of Gastric Contents in Fasted Surgical Patients With Previous Subtotal Gastrectomy | November 15, 2018 | December 15, 2020 | |
| NCT01858220 | Unknown status | IS There a Correlation Between Sypmtoms of Gastroparesis and the Duration of Video Caspule Retention in the Stomach | January 2013 | January 2015 | |
| NCT04250844 | Unknown status | Use of Intrapyloric Botulinum Injections in Children | March 10, 2020 | May 2021 | |
| NCT00777439 | Unknown status | N/A | Domperidone for Refractory Gastrointestinal Disorders | October 2008 | January 2018 |
| NCT03500354 | Withdrawn | N/A | Nutritional Drink in Gastroparesis | May 10, 2019 | January 2024 |
| NCT04894656 | Withdrawn | N/A | Intestinal Permeability and Gastroparesis | April 1, 2022 | July 2023 |
| NCT05223881 | Withdrawn | N/A | Gastroparesis in Cystic Fibrosis | February 14, 2022 | March 30, 2023 |
| NCT04501211 | Withdrawn | Phase 2 | Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis | January 1, 2019 | December 31, 2021 |
| NCT00568373 | Withdrawn | N/A | Gastric Pacemaker Implantation for Gastroparesis | June 2007 | December 2025 |
| NCT01378884 | Withdrawn | Phase 3 | The Use of Domperidone for Gastroparesis | March 2010 | March 2014 |
| NCT01326117 | Withdrawn | Phase 4 | Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis | April 2011 | December 2013 |
| NCT02420925 | Withdrawn | N/A | Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis | October 2014 | June 2016 |
| NCT05229107 | Withdrawn | N/A | Cereset Research For Chronic Nausea | March 2024 | March 7, 2024 |
| NCT05055336 | Withdrawn | N/A | Longitudinal Evaluation of Gastric Emptying and Accommodation in Children With Dyspepsia | May 1, 2022 | April 1, 2023 |
| NCT03036891 | Withdrawn | Phase 2 | Naloxegol for Opioid-Related Gastroparesis | December 29, 2016 | September 30, 2019 |
- Disase is a (Disease Ontology)
- DOID:1159
- Cross Reference ID (Disease Ontology)
- ICD10CM:K31.84
- Cross Reference ID (Disease Ontology)
- ICD9CM:536.3
- Cross Reference ID (Disease Ontology)
- MESH:D018589
- Cross Reference ID (Disease Ontology)
- NCI:C80512
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:235675006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0152020
- Exact Synonym (Disease Ontology)
- gastric atonia
- Exact Synonym (Disease Ontology)
- Gastroparalysis
- Exact Synonym (Disease Ontology)
- Gastroparesis syndrome
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002578
- MedGen concept unique identifier (MedGen Concept name)
- C0152020
- MedGen unique identifier (MedGen Concept name)
- 101809
- MeSH unique ID (MeSH (Medical Subject Headings))
- D018589